Authors
Loading...
Experimental molecular study reveals that c-Cbl acts as a RING-type ubiquitin ligase targeting activated receptor tyrosine kinases, uncovering a distinct mechanism for substrate degradation.
Joazeiro et al. (1999) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: